West Pharmaceutical Services Income from Continuous Operations 2010-2024 | WST
West Pharmaceutical Services annual/quarterly income from continuous operations history and growth rate from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- West Pharmaceutical Services income from continuous operations for the quarter ending September 30, 2024 was $0.136B, a 15.69% decline year-over-year.
- West Pharmaceutical Services income from continuous operations for the twelve months ending September 30, 2024 was $0.500B, a 10.69% decline year-over-year.
- West Pharmaceutical Services annual income from continuous operations for 2023 was $0.593B, a 1.28% increase from 2022.
- West Pharmaceutical Services annual income from continuous operations for 2022 was $0.586B, a 11.47% decline from 2021.
- West Pharmaceutical Services annual income from continuous operations for 2021 was $0.662B, a 91.16% increase from 2020.
West Pharmaceutical Services Annual Income from Continuous Operations
(Millions of US $) |
| 2023 |
$593 |
| 2022 |
$586 |
| 2021 |
$662 |
| 2020 |
$346 |
| 2019 |
$242 |
| 2018 |
$207 |
| 2017 |
$151 |
| 2016 |
$144 |
| 2015 |
$96 |
| 2014 |
$127 |
| 2013 |
$112 |
| 2012 |
$81 |
| 2011 |
$76 |
| 2010 |
$65 |
| 2009 |
$73 |
West Pharmaceutical Services Quarterly Income from Continuous Operations
(Millions of US $) |
| 2024-09-30 |
$136 |
| 2024-06-30 |
$111 |
| 2024-03-31 |
$115 |
| 2023-12-31 |
$137 |
| 2023-09-30 |
$161 |
| 2023-06-30 |
$155 |
| 2023-03-31 |
$140 |
| 2022-12-31 |
$103 |
| 2022-09-30 |
$121 |
| 2022-06-30 |
$189 |
| 2022-03-31 |
$174 |
| 2021-12-31 |
$148 |
| 2021-09-30 |
$176 |
| 2021-06-30 |
$187 |
| 2021-03-31 |
$151 |
| 2020-12-31 |
$98 |
| 2020-09-30 |
$82 |
| 2020-06-30 |
$91 |
| 2020-03-31 |
$74 |
| 2019-12-31 |
$64 |
| 2019-09-30 |
$56 |
| 2019-06-30 |
$66 |
| 2019-03-31 |
$55 |
| 2018-12-31 |
$52 |
| 2018-09-30 |
$55 |
| 2018-06-30 |
$56 |
| 2018-03-31 |
$44 |
| 2017-12-31 |
|
| 2017-09-30 |
$51 |
| 2017-06-30 |
$39 |
| 2017-03-31 |
$61 |
| 2016-12-31 |
$39 |
| 2016-09-30 |
$38 |
| 2016-06-30 |
$45 |
| 2016-03-31 |
$22 |
| 2015-12-31 |
$33 |
| 2015-09-30 |
$2 |
| 2015-06-30 |
$28 |
| 2015-03-31 |
$33 |
| 2014-12-31 |
$31 |
| 2014-09-30 |
$31 |
| 2014-06-30 |
$38 |
| 2014-03-31 |
$27 |
| 2013-12-31 |
$24 |
| 2013-09-30 |
$27 |
| 2013-06-30 |
$30 |
| 2013-03-31 |
$32 |
| 2012-12-31 |
$21 |
| 2012-09-30 |
$15 |
| 2012-06-30 |
$16 |
| 2012-03-31 |
$29 |
| 2011-12-31 |
$19 |
| 2011-09-30 |
$17 |
| 2011-06-30 |
$20 |
| 2011-03-31 |
$20 |
| 2010-12-31 |
$6 |
| 2010-09-30 |
$18 |
| 2010-06-30 |
$22 |
| 2010-03-31 |
$20 |
| 2009-12-31 |
$20 |
| 2009-09-30 |
$17 |
| 2009-06-30 |
$20 |
| 2009-03-31 |
$15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$22.024B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
